Yvette Delph

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial”.

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00147-9

N/A

0.869DataRank · unranked

19 citations

Christina E. Barkauskas, Birgit Grund, Shweta Sharma, Andrew Phillips, Lindsay Leither +95 more

ACTIV trials: cross-trial lessons learned for master protocol implementation

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.507

N/A

0DataRank · unranked

3 citations

Stacey J. Adam, Indira Brar, Lucy Chung, Judith S. Currier, Eric S. Daar +16 more

Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.485

N/A

0DataRank · unranked

1 citations

Rubria Marines‐Price, Olga Milman, Danae Deal, Jonathan Marchand, Jessica Linton +7 more